MED
Get informed when a big investor buys or sells
+ FollowUndervalued by 341% based on the discounted cash flow analysis.
| Market cap | $114.08 Million |
|---|---|
| Enterprise Value | $58.65 Million |
| Dividend Yield | $6.59 (-) |
| Earnings per Share | $-1.7 |
| Beta | 0.68 |
| Outstanding Shares | 11,006,000 |
| P/E Ratio | -5.64 |
|---|---|
| PEG | -3.22 |
| Price to Sales | 0.3 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 0.17 |
| Enterprise Value to EBIT | -4.18 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.08 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 3.51% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.82%▼ 77.52% |
|---|---|
| Total Invested | $962,538▼ 98.90% |
| Investors Holding | 10▼ 110.00% |
No data
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...